CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-25 | SHANNON TIMOTHY M Director | Sale | −11,456 | $10.02 | $115K | 4,551,359 |
| 2016-05-25 | Canaan IX L.P. Director | Sale | −11,456 | $10.02 | $115K | 4,551,359 |
| 2016-05-24 | SHANNON TIMOTHY M Director | Sale | −1,200 | $10.00 | $12K | 4,562,815 |
| 2016-05-24 | Canaan IX L.P. Director | Sale | −1,200 | $10.00 | $12K | 4,562,815 |
| 2016-05-23 | SHANNON TIMOTHY M Director | Sale | −12,053 | $10.10 | $122K | 4,564,015 |
| 2016-05-23 | Canaan IX L.P. Director | Sale | −12,053 | $10.10 | $122K | 4,564,015 |
| 2016-05-20 | SHANNON TIMOTHY M Director | Sale | −6,187 | $10.09 | $62K | 4,576,068 |
| 2016-05-20 | Canaan IX L.P. Director | Sale | −6,187 | $10.09 | $62K | 4,576,068 |
| 2016-05-19 | SHANNON TIMOTHY M Director | Sale | −2,500 | $10.14 | $25K | 4,582,255 |
| 2016-05-19 | Canaan IX L.P. Director | Sale | −2,500 | $10.14 | $25K | 4,582,255 |
| 2016-05-12 | Goeltz II Robert C. Chief Financial Officer | Option exercise | +2,000 | $4.47 | $9K | 2,000 |
| 2016-05-12 | Goeltz II Robert C. Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −2,000 | 245,675 | ||
| 2016-04-25 | Canaan IX L.P. Director | Other disposition | −300,000 | 4,584,755 | ||
| 2016-04-05 | GLUCK FREDERICK W Director | Other acquisition | +331,643 | 331,643 | ||
| 2016-04-05 | GLUCK FREDERICK W Director | Other acquisition | +17,111 | 22,111 | ||
| 2016-01-21 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Grant or award · Employee Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2016-01-21 | LADD CYNTHIA J Senior VP and General Counsel | Grant or award · Employee Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2016-01-21 | Goeltz II Robert C. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2016-01-21 | HUMPHREY RACHEL Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2016-01-21 | McCarthy Sean A. President and CEO | Grant or award · Employee Stock Option (right to buy) | +225,000 | 225,000 |
Page 31 of 33 · 649 trades